5th Annual Frost & Sullivan India Healthcare Excellence Awards 2013
27 September, 2013.
ICRI Health also announced the appointment of Dr M Srivastava, former professor of hospital administration, University of Pune and a pioneer of healthcare management services associated with various prestigious institutes like the Armed Forces Medical College, Pune, AIIMS, IGNOU, etc, as director (Health Services) - ICRI Health.
"The launch of this new division also marks four years of ICRI's successful existence in the field of education" , said S R Dugal, chairman, board of directors, ICRI. Besides, ICRI Health also declared its alliance with Academy of Hospital Administration (AHA) for jointly conducting hospital operations management and healthcare industry related courses.
ICRI Health, a division of ICRI India, claims to be the pioneer of the allied healthcare education courses in India and aims to develop the healthcare sector and support professionals in the Indian health care industry.
"The institute aims to be a leader in scientific health care management education and seeks to introduce well defined processes into the marketing of the healthcare segment and hospital administration in India and help bridge the gap by offering well trained professionals for the medical tourism and hospital operations management industry. For the medical tourism course, faculty from Singapore Health (Singapore) will be teaching the modules in India," said Dugal.
The industry-centric job oriented courses at ICRI are said to be developed in association with the corporate world. The faculty drawn from the industry and academia are from medical , management and tourism sectors. The institute has large, well-equipped campuses in Delhi, Mumbai, Ahmedabad, Kochi, Hyderabad and Bangalore.
According to a study by McKinsey and the Confederation of Indian Industry, medical tourism in India could become a $1 billion business by 2012. The report predicts that: "By 2012, if medical tourism were to reach 25 per cent of revenues of private up-market players, up to 2,297,794,117 USD will be added to the revenues of these players."
The Indian government predicts that India's $17-billion-a-year health-care industry could grow 13 per cent in each of the next six years, boosted by medical tourism, which industry watchers say is growing at 30 per cent annually. For long promoted for its cultural and scenic beauty, India is now being put up on international map as a heaven for those seeking quality and affordable healthcare. Analysts say that as many as 150,000 medical tourists came to India in 2004.
"As Indian corporate hospitals are on par, if not better than the best hospitals in Thailand, Singapore, etc there is scope for improvement, and the country is becoming a preferred medical destination specially for the African nations, SAARC countries, Middle East and European nations apart from the US and UK . In addition to the increasingly top class medical care, a big draw for foreign patients is also the very minimal or hardly any waitlist as is common in European or American hospitals" , added Dugal.
Apparently, more and more tourists are choosing India as their medical treatment destination because it has a rich cultural heritage and innumerable tourist destinations. And here, ICRI can strive hard to be the future torch bearer for similar institutes in India.
It can bring in a paradigm shift in the healthcare and wellness segment using the science of management and training to ensure continuity, maximise capacity and improve quality of care. "India has a huge potential in terms of capability and quality and this is what we need to harness today in the healthcare and wellness segment" , said Dugal.
New Delhi: The Institute of Clinical Research India (ICRI) has tied up with Academy of Hospital Administration (AHA) to start teaching healthcare management in the country.
The initiative is aimed at providing qualified manpower to the booming medical tourism sector in India, reports IANS.
"We wish to bring in a paradigm shift in the healthcare and wellness segment using the science of management and training to ensure continuity, maximise capacity and improve quality of care," ICRI Chairman S R Dugal said.
"India has a huge potential in terms of capability and quality and this is what we need to harness today in the healthcare and wellness segment," he added.
According to a McKinsey and the Confederation of Indian Industry (CII) study, medical tourism in India has the potential to become a $1 billion business by 2012.
The government has predicted that India's $17-billion-a-year healthcare industry could grow 13 per cent in each of the next six years, boosted by medical tourism.
ICRI is one of India's leading clinical research institutes and currently operates out of Delhi, Mumbai, Ahmedabad, Kochi, Hyderabad and Bangalore.
An Indian health education group has announced courses in hospital management and medical tourism-- intended to tap into a burgeoning healthcare industry at home and care-seekers from abroad.
From a ''few small charitable hospitals (to) world class corporate modern hospitals,'' India’s healthcare industry ‘’has come a long way,’’ Shiv Raman Dugal, chairman of the Institute of Clinical Research (India) told journalists this week.
The $17-billion-a-year-- and growing-- industry is estimated to employ four million people serving the needs of a sixth of world population suffering from a fifth of its ailments.
For the past four years, the Institute has been running a postgraduate clinical research course turning out professionals trained to conduct trials of new drugs, medical devices and procedures.
Dugal said the new courses would inject scientific management concepts and practices into hospital operations "hitherto handled by medical superintendents" as well as in medical tourism, which drew 150,000 travellers to India in 2004.
These courses will be administered by the Institute's newly created Health Division headed by Major General (retired) Munindra Srivastava.
Dr Srivastasva said monthly pay packages in healthcare industry could be as high as Rs 50,000 at entry level and Rs 1,50,000 to 2,50,000 for experienced professionals.
Institute officials say manpower deficiency in a booming healthcare industry underscores the need for scientific management with marketing strategies.
The bulk of India's healthcare spending is in private sector. It ranks 171st among 175 countries in Public Health Sector spending and 17th in Private Sector spending.
The spending has more than doubled in just over a decade from Rs 86,000 crore in 1991 to a projected Rs 200,000 crore in 2012-- Rs 156,000 crore of it in private sector.
Explaining medical tourism, Dr Srivastava said the idea was to provide state-of-the-art private medical care in collaboration with tourism industry to foreign patients at highly competitive prices compared to hospitals in the West.
Medical procedures in India cost a tenth or less of what they cost in the West. For instance, a metal-free dental bridge which costs $5,500 in the US, costs only $500 in India.
He said India was now a leading promoter of medical tourism moving into an era of 'medical outsourcing' with sub-contractors providing services to over-burdened and high priced Western facilities.
Experts say the concept dates back thousands of years when Greek pilgrims all over the Mediterranean travelled to a small territory in the Saronic Gulf called Epidauria-- home of the healer god Asklepios. Spa towns and sanitariums were also early form of medical tourism, they say.
Institute officials see medical and health tourism as ''the next big success story of India,'' packaging medical treatment with recuperative leisure at resorts.
Besides high prices and insurance complications, Western destinations such as Britain and Canada pose long waiting periods.
In Canada, for instance, as many as 782,936 patients waited for procedures in 2005, they said.
A study commissioned by the Confederation of Indian Industry showed that 1.3 million medical tourists visit Asia annually and some 710,000 Americans seek cheaper care abroad.
The Institute says India ''has some of the best corporate hospitals and treatment centres in the world''-- with hospital infrastructure and technology on a par with the United States and Britain.
At least for now, there is no waiting period and a 98.7 per cent procedure success rate as compared to 97.5 per cent in the U S.
Asked how the Institute will equip graduates to deal with such trends as illegal kidney transplants or unauthorised drug-testing, Brigadier (retired) Dr K S Bhatnagar, a course consultant, said the curriculum includes studies on Law and Health.
The goal, according to an Institute brochure, is to meet ''the growing demand of skilled clinical research professionals in the future... with a primary focus on promoting ethical research.'' The issue of ethics arises owing to reports from time to time of drug-makers testing new concoctions without adequate approvals or accountability.
Asked whether an upsurge in clinical testing activity might raise the risk of patient or subject abuse, Institute spokesmen cited steps taken by the Indian Council of Medical Research to promote ethics.
Last year, the Council launched a Registry for Clinical Trials aimed at transparency in such trials and consequent requirements that any adverse effects be treated and subjects compensated-- not left in the lurch.
But the Council Registry is a voluntary affair, not a requirement, implying that trials might still be conducted without its knowledge, albeit journals may not publish such findings.
Experts say that is hardly a consolation to any victims should unregistered experiments fail or induce harm.
They say that while schools can instill correct values, a far more effective role has to be played by regulation through meaningful laws and enforcement.
According to published sources, drug corporations which have to reckon with strict regulatory norms or legal actions in, for instance, the United States, eye India, with its millions of untreated patients, as an advantageous ‘’resource.’’ For instance, California-based iGATE Corporation, listed among top clinical research global outsourcers, says India ‘’represents a largely untapped resource for clinical trials.'' Among pluspoints, it cites are huge patient base, diversity of diseases, heterogeneous population mix, drug naïve population, high enrollment rates, state-of-the-art hospital facilities, reliable, well-trained, experienced investigators, competitive costs and ''increasingly accommodating'' regulatory environment.
A morbidity list for India put out by iGATE includes 40 million asthmatic patients, 34 million diabetic patients, 8-10 million people HIV positive, eight million epileptic patients, three million cancer patients, two million cardiac related deaths, 1.5 million Alzheimer’s victims, 15 per cent of population is hypertensive and one per cent suffer from schizophrenia.
Riding the healthcare boom in the country, the Institute of Clinical Research India (ICRI) yesterday announced the launch of its healthcare division - ICRI HEALTH.
The division will focus on imparting structured and relevant education and bringing in the science of management into healthcare services – both for medical tourism and hospital operations management.
ICRI HEALTH also announced the appointment of Major General (Dr) M. Srivastava, VSM (Retd.), former professor of Hospital Administration, University of Pune and a pioneer of healthcare management services associated with various prestigious institutes like the Armed Forces Medical College, Pune, AIIMS and IGNOU.
ICRI HEALTH has entered into an MOU with Academy of Hospital Administration (AHA) for jointly conducting hospital operations management and healthcare industry related courses.
On this occasion S R Dugal, chairman, board of directors, ICRI said, “The healthcare industry in India has come a long way. We wish to bring in a paradigm shift in the healthcare and wellness segment using the science of management and training to ensure continuity, maximize capacity and improve quality of care. India has a huge potential in terms of capability and quality and this is what we need to harness today in the healthcare and wellness segment. As an institute, we are constantly benchmarking ourselves to international best practices in our domain of education and we aim to be the future torch bearer for similar institutes in India.”
According to a study by McKinsey and the Confederation of Indian Industry, medical tourism in India could become a $1 billion business by 2012, claimed Duggal.
“More and more tourists are choosing India as their medical treatment destination because it has a rich cultural heritage and innumerable tourist destinations. The other advantages are that metros have good infrastructure, majority of the population speak English and that Indian surgeons have world class skills and surgical exposure”, he added.
Admissions on for 7th Batch (2011-2013) of M.Sc in Clinical Research (Cranfield University, UK)
Admissions on for 2nd Batch (2011-2013) of MS in Clinical Research (Medical University of South Carolina, USA) in Hyderabad and Dehradun campuses
Admissions on for 1st Batch (2011-2013) of M.Sc. in Clinical Trials (IGNOU)